Investing.com - Bionano Genomics (NASDAQ: BNGO) reported first quarter EPS of $-0.109, worse than the analyst estimate of $-0.100. Revenue for the quarter came in at $7.4M versus the consensus estimate of $7.22M.
Bionano Genomics's stock price closed at $0.740. It is down -52.560% in the last 3 months and down -39.590% in the last 12 months.
Bionano Genomics saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Bionano Genomics's stock price’s past reactions to earnings here.
According to InvestingPro, Bionano Genomics's Financial Health score is "fair performance".
Check out Bionano Genomics's recent earnings performance, and Bionano Genomics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar